Literature DB >> 219935

High-density lipoprotein in chronic renal failure and after renal transplantation.

E Savdie, J C Gibson, J H Stewart, L A Simons.   

Abstract

Serum high-density-lipoprotein (HDL) cholesterol and apoprotein (apo) A concentrations were significantly reduced at the time of renal transplantation in 26 patients with chronic renal failure. In a prospective evaluation the behaviour of HDL concentrations after grafting was found to depend on renal function. Graft function was sustained in 19 patients, in whom HDL-cholesterol and apo A concentrations increased to lie within normal limits by six months after the operation. Successful transplantation also restored to normal the lipid and protein content of HDL as expressed by the ratio of HDL cholesterol to apo A. When transplant function was not sustained (seven patients), however, no changes in HDL were observed up to the time of the graft loss. Such changes in HDL with successful kidney grafting augur well in a population with many risk factors for coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219935      PMCID: PMC1598619          DOI: 10.1136/bmj.1.6168.928

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  24 in total

1.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study.

Authors:  W B KANNEL; T R DAWBER; A KAGAN; N REVOTSKIE; J STOKES
Journal:  Ann Intern Med       Date:  1961-07       Impact factor: 25.391

2.  Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients.

Authors:  J D Bagdade; J J Albers
Journal:  N Engl J Med       Date:  1977-06-23       Impact factor: 91.245

3.  Serum lipoprotein abnormalities in renal allograft recipients.

Authors:  L K Abbott; C Elliot; J M Aitken; J B Somer
Journal:  Atherosclerosis       Date:  1978-06       Impact factor: 5.162

4.  H.D.L. cholesterol: the variable components.

Authors:  D W Anderson
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

5.  Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake.

Authors:  P Belfrage; B Berg; I Hägerstrand; P Nilsson-Ehle; H Tornqvist; T Wiebe
Journal:  Eur J Clin Invest       Date:  1977-04       Impact factor: 4.686

6.  Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.

Authors:  L S Ibels; J H Stewart; J F Mahony; F C Neale; A G Sheil
Journal:  Q J Med       Date:  1977-04

7.  Prevalence of serum lipid abnormalities in chronic hemodialysis.

Authors:  J D Brunzell; J J Albers; L B Haas; A P Goldberg; L Agadoa; D J Sherrard
Journal:  Metabolism       Date:  1977-08       Impact factor: 8.694

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

10.  Plasma-triglycerides in regulation of H.D.L.-cholesterol levels.

Authors:  E J Schaefer; R I Levy; D W Anderson; R N Danner; H B Brewer; W C Blackwelder
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

View more
  4 in total

1.  Blood protein binding of cyclosporine in transplant patients.

Authors:  I Zaghloul; R J Ptachcinski; G J Burckart; D Van Thiel; T E Starzel; R Venkataramanan
Journal:  J Clin Pharmacol       Date:  1987-03       Impact factor: 3.126

Review 2.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

3.  Corticosteroid treatment, serum lipids and coronary artery disease.

Authors:  D B Jefferys; M H Lessof; M B Mattock
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

Review 4.  Endocrine and metabolic abnormalities following kidney transplantation.

Authors:  W H Hörl; W Riegel; C Wanner; M Haag-Weber; P Schollmeyer; H Wieland; H Wilms
Journal:  Klin Wochenschr       Date:  1989-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.